Prescription Drug Ads Only two countries -- the United States and New Zealand -- allow prescription drug ads on television. Thanks to these ads, we've all heard of the little purple pill and can probably name two sources of cholesterol. But is a little knowledge a dangerous thing? Ira Flatow leads a discussion on the pros and cons of allowing drug ads on TV.
NPR logo

Prescription Drug Ads

  • Download
  • <iframe src="https://www.npr.org/player/embed/5315159/5315160" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript
Prescription Drug Ads

Prescription Drug Ads

Prescription Drug Ads

  • Download
  • <iframe src="https://www.npr.org/player/embed/5315159/5315160" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Only two countries — the United States and New Zealand — allow prescription drug ads on television. Thanks to these ads, we've all heard of the little purple pill and can probably name two sources of cholesterol. But is a little knowledge a dangerous thing? Ira Flatow leads a discussion on the pros and cons of allowing drug ads on TV.

Guests:

John Kamp, executive director, Coalition for Healthcare Communication.

Richard Kravitz, professor, internal medicine and director, Center for Health Services Research in Primary Care at the University of California, Davis.

Robert Centor, professor, internal medicine, University of Alabama School of Medicine at the University of Alabama at Birmingham.